Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study.
Wagner LM, Perentesis JP, Reid JM, Ames MM, Safgren SL, Nelson MD Jr, Ingle AM, Blaney SM, Adamson PC. Wagner LM, et al. Among authors: blaney sm. Pediatr Blood Cancer. 2010 Apr;54(4):538-45. doi: 10.1002/pbc.22407. Pediatr Blood Cancer. 2010. PMID: 20049936 Free PMC article. Clinical Trial.
Acute pancreatitis after ifosfamide therapy.
Izraeli S, Adamson PC, Blaney SM, Balis FM. Izraeli S, et al. Among authors: blaney sm. Cancer. 1994 Sep 1;74(5):1627-8. doi: 10.1002/1097-0142(19940901)74:5<1627::aid-cncr2820740522>3.0.co;2-u. Cancer. 1994. PMID: 8062195
Phase II evaluation of topotecan for pediatric central nervous system tumors.
Blaney SM, Phillips PC, Packer RJ, Heideman RL, Berg SL, Adamson PC, Allen JC, Sallan SE, Jakacki RI, Lange BJ, Reaman GH, Horowitz ME, Poplack DG, Balis FM. Blaney SM, et al. Cancer. 1996 Aug 1;78(3):527-31. doi: 10.1002/(SICI)1097-0142(19960801)78:3<527::AID-CNCR21>3.0.CO;2-#. Cancer. 1996. PMID: 8697400 Clinical Trial.
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
Adamson PC, Reaman G, Finklestein JZ, Feusner J, Berg SL, Blaney SM, O'Brien M, Murphy RF, Balis FM. Adamson PC, et al. Among authors: blaney sm. J Clin Oncol. 1997 Nov;15(11):3330-7. doi: 10.1200/JCO.1997.15.11.3330. J Clin Oncol. 1997. PMID: 9363862 Clinical Trial.
223 results